CINACALCET
Clinical Indication
Secondary hyperparathyroidism
Comments
Shared care request is mandatory
Full SCA
Date of classification
July 2008
Orange
Shared Care Agreement. Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.